Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus plus mycophenolate mofetil versus tacrolimus plus everolimus for recurrent hepatitis C after liver transplantation
2012-002105-22Phase 2Completed
- Sponsor
- Dra. Itxarone Bilbao
- Start
- Jun 2012
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus, mycophenolate mofetil, everolimus in hepatitis C virus infection, sponsored by Dra. Itxarone Bilbao. Started Jun 2012; status: completed.
02
Drugs
tacrolimusmycophenolate mofetileverolimus
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2012-002105-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002105-22.